Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Shifts in the Human Gut Microbiota Structure Caused by Quadruple Helicobacter pylori Eradication Therapy
Evgenii I. Olekhnovich, Alexander I. Manolov, Andrei E. Samoilov, et al.
Frontiers in Microbiology (2019) Vol. 10
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report
Peter Malfertheiner, Françis Mégraud, Theodore Rokkas, et al.
Gut (2022) Vol. 71, Iss. 9, pp. 1724-1762
Open Access | Times Cited: 741
Using Probiotics as Supplementation for Helicobacter pylori Antibiotic Therapy
Jianfu Ji, Hong Yang
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 1136-1136
Open Access | Times Cited: 116
Recent progress in Helicobacter pylori treatment
Yi Hu, Yin Zhu, Nonghua Lü
Chinese Medical Journal (2020) Vol. 133, Iss. 3, pp. 335-343
Open Access | Times Cited: 85
Unveiling the gastric microbiota: implications for gastric carcinogenesis, immune responses, and clinical prospects
Zhiyi Liu, Dachuan Zhang, Siyu Chen
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 10
Weizmannia coagulans BC99 modulate gut microbiota after Helicobacter pylori eradication: A randomized double-blind placebo-controlled trial
Ying Wu, Shirui Zhai, Caie Wang, et al.
Journal of Functional Foods (2025) Vol. 125, pp. 106681-106681
Closed Access
Gut Microbiota: The Missing Link Between Helicobacter pylori Infection and Metabolic Disorders?
Gracia María Martín‐Núñez, Isabel Cornejo‐Pareja, Mercedes Clemente‐Postigo, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 48
Second-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial
Jyh‐Ming Liou, Xiaotao Jiang, Chieh‐Chang Chen, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 8, Iss. 3, pp. 228-241
Closed Access | Times Cited: 33
Exploring the impact of Helicobacter pylori and potential gut microbiome modulation
Isaac Jingkhai Ong, Ke-Yan Loo, Lydia Ngiik-Shiew Law, et al.
Progress In Microbes & Molecular Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 16
Changes in the human gut microbiota composition caused by Helicobacter pylori eradication therapy: A systematic review and meta‐analysis
Qunqun Ye, Xiaona Shao, Ruiwei Shen, et al.
Helicobacter (2020) Vol. 25, Iss. 4
Closed Access | Times Cited: 46
The impacts of probiotics in eradication therapy of Helicobacter pylori
Xiaofen Bai, Minjie Zhu, Yajun He, et al.
Archives of Microbiology (2022) Vol. 204, Iss. 12
Open Access | Times Cited: 23
Dynamic changes in the gut microbiota after bismuth quadruple therapy and high‐dose dual therapy for Helicobacter pylori eradication
Jing Chen, Yan Zhang, Hanchen Min, et al.
Helicobacter (2024) Vol. 29, Iss. 2
Closed Access | Times Cited: 3
Treatment of Helicobacter pylori infection and its long‐term impacts on gut microbiota
Jyh‐Ming Liou, Yi‐Chia Lee, Ming‐Shiang Wu
Journal of Gastroenterology and Hepatology (2020) Vol. 35, Iss. 7, pp. 1107-1116
Closed Access | Times Cited: 31
Changes in Gastric Corpus Microbiota With Age and After Helicobacter pylori Eradication: A Long-Term Follow-Up Study
Cheol Min Shin, Nayoung Kim, Ji Hyun Park, et al.
Frontiers in Microbiology (2021) Vol. 11
Open Access | Times Cited: 30
Long‐term changes in the gut microbiota after 14‐day bismuth quadruple therapy in penicillin‐allergic children
Ying Zhou, Ziqing Ye, Junping Lu, et al.
Helicobacter (2020) Vol. 25, Iss. 5
Closed Access | Times Cited: 30
Helicobacter pylori infection and eradication: Exploring their impacts on the gastrointestinal microbiota
Zhihang Tao, Ji‐Xuan Han, Jing‐Yuan Fang
Helicobacter (2020) Vol. 25, Iss. 6
Closed Access | Times Cited: 27
RETRACTED ARTICLE: The role of bismuth nanoparticles in the inhibition of bacterial infection
Somaye Salari Sedigh, Arsalan Gholipour, Mahdiyeh zandi, et al.
World Journal of Microbiology and Biotechnology (2023) Vol. 39, Iss. 7
Open Access | Times Cited: 8
Butyric Acid Supplementation Reduces Changes in the Taxonomic and Functional Composition of Gut Microbiota Caused by H. pylori Eradication Therapy
Sayar Abdulkhakov, Maria Markelova, Dilyara Safina, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 319-319
Open Access | Times Cited: 2
14‐day tailored PCR‐guided triple therapy versus 14‐day non‐Bismuth concomitant quadruple therapy for Helicobacter pylori eradication: A multicenter, open‐label randomized noninferiority controlled trial
Aurélien Amiot, Jérémy Hacoon, Frédéric Heluwaert, et al.
Helicobacter (2024) Vol. 29, Iss. 2
Closed Access | Times Cited: 2
Development of qPCR platform with probes for quantifying prevalent and biomedically relevant human gut microbial taxa
Irina Kurina, Anna Popenko, Natalia Klimenko, et al.
Molecular and Cellular Probes (2020) Vol. 52, pp. 101570-101570
Open Access | Times Cited: 24
The Eradication of Helicobacter pylori Was Significantly Associated with Compositional Patterns of Orointestinal Axis Microbiota
Sally Ali Tawfik, Marwa Azab, Mohammed Ramadan, et al.
Pathogens (2023) Vol. 12, Iss. 6, pp. 832-832
Open Access | Times Cited: 7
Dynamic changes in antibiotic resistance genes and gut microbiota after Helicobacter pylori eradication therapies
Lingling Wang, Haobin Yao, Teresa Tong, et al.
Helicobacter (2021) Vol. 27, Iss. 2
Closed Access | Times Cited: 19
Long‐term changes in the gut microbiota after triple therapy, sequential therapy, bismuth quadruple therapy and concomitant therapy for Helicobacter pylori eradication in Chinese children
Ying Zhou, Ziqing Ye, Yuhuan Wang, et al.
Helicobacter (2021) Vol. 26, Iss. 4
Closed Access | Times Cited: 16
Saccharomyces boulardii CNCM I‐745 supplementation modifies the fecal resistome during Helicobacter pylori eradication therapy
Sara G. Cifuentes, María Belén Prado, Marco Fornasini, et al.
Helicobacter (2022) Vol. 27, Iss. 2
Closed Access | Times Cited: 11
Potential of Bacterial Cellulose Chemisorbed with Anti-Metabolites, 3-Bromopyruvate or Sertraline, to Fight against Helicobacter pylori Lawn Biofilm
Paweł Krzyżek, Grażyna Gościniak, Karol Fijałkowski, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 24, pp. 9507-9507
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top